32
Pharma & HealthcareAvoid
Nippon India Pharma
Nippon India · Direct–Growth · rank #14 / 19 Smart Score ke hisaab se
Data updated
Nippon India Pharma ka score 32/100 hai — 19 mein #14 Pharma & Healthcare fund (Avoid). Mazbooti: fund size (category mein 97th percentile). Kamzori: 3 saal ka return (category mein 4th percentile).
Trailing returns
index ke muqable: Nifty 500 (index-fund proxy)1 saal
3.2%
+10.3% index ke muqable
3 saal
16.1%
+7.0% index ke muqable
5 saal
12.8%
+4.9% index ke muqable
Launch se
16.8%
Saal-dar-saal performance
aakhri entry = is saal ab tak2021
25.1%
2022
-9.1%
2023
40.4%
2024
35.3%
2025
-2.5%
2026
4.5%
Risk metrics
Sharpe ratio
0.81
↑ jitna zyada, utna accha
Sortino ratio
1.11
↑ jitna zyada, utna accha
Std deviation
15.09
↓ jitna kam, utna accha
Alpha
1.09
↑ jitna zyada, utna accha
Beta
0.85
≈1 yaani market ke saath
Isi category ke aur funds
Research aur education ke liye — investment advice nahi.